DPP4 and type 2 diabetes mellitus: Recently, DPP-4 inhibitors are commonly used in various individuals with type 2 diabetes mellitus (T2DM) from the young to the elderly because of their good glucose-lowering effect and safety including low risk of hypoglycaemia.